Search results
StockNews.com Initiates Coverage on Can-Fite BioPharma (NYSE:CANF)
ETF DAILY NEWS· 5 days agoStockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Wednesday morning. The brokerage issued a hold rating on the stock. Can-Fite ...
Dermatologists Reveal What Drinking Water Can Do For Your Skin
HuffPost Life via Yahoo News· 3 days agoCasey also adds that sugar and other high-glycemic index foods have been linked to acne. “Likewise,...
Mediterranean diet: Benefits, heart health and weight loss
The Telegraph via Yahoo News· 6 days agoAutoimmune conditions Several studies have shown that the Med diet is anti-inflammatory and can help...
The 16 Best CeraVe Products Skin Experts Would Buy Again and Again
Elle via Yahoo News· 7 days ago“This is one of my favorite body moisturizers of all time. It is so great for people with skin...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 6 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
10 Stars You Won't Believe Are 70: Christie Brinkley, John Travolta and More
OK! Magazine· 3 days agoBorn on May 24, 1953, Alfred Molina looks younger than his age. At 70, he has already starred in...
Ankylosing spondylitis and female hormones
Medical News Today· 6 days agoMost studies investigating the effect of female hormones on the condition consider the role of estrogen. To date, however, this research has not been...
Can-Fite receives FDA IND clearance for Phase IIb MASH treatment trial
Clinical Trials Arena via Yahoo Finance· 6 days agoIIa study, we are proud to develop a new potential treatment to address this disease.” In August...
MoonLake Immunotherapeutics’ (MLTX) Buy Rating Reiterated at Needham & Company LLC
ETF DAILY NEWS· 5 days agoNeedham & Company LLC reissued their buy rating on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports ...
Principal Securities Inc. Takes $3.63 Million Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 3 days agoPrincipal Securities Inc. acquired a new position in Johnson & Johnson (NYSE:JNJ – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional ...